Under the continuous efforts of the policy, the supervision of shortage drugs is continuously strengthened

[Pharmaceutical Network Policy and Regulations] Shortage drugs are usually defined as drugs that are clinically necessary and cannot be normally supplied within a certain period of time, including drug varieties with uncertain dosage, low prices, infrequent production by enterprises and frequent supply shortages in the region
.

The stable supply and price of drugs in short supply has always been a concern for people's livelihood
.

Therefore, in order to ensure the medication needs of each patient, the state is continuously issuing relevant documents to ensure the supply of drugs in short supply
.

Recently, the four ministries and commissions of the National Health Commission, the National Medical Insurance Administration, the State Food and Drug Administration, and the Ministry of Industry and Information Technology jointly issued a notice stating that 109 shortage drug preparations, 60 shortage drug APIs, and 240 nationally sourced drugs will be selected.
Drug production enterprises shall monitor production reserves, and implement dynamic adjustments to the list of monitoring enterprises
.

The notice clearly pointed out that before the 10th of each month, the production enterprises of drugs in shortage and the production enterprises of selected drugs in centralized procurement should fill in the "Monitoring Report of Production and Supply of Shortaged Drugs in Pharmaceutical Industry Enterprises" and "National Centralized Procurement of Drug Production and Supply" through the "Monitoring and Early Warning Platform for Production and Supply of Shortaged Drugs".
"Monitoring Report", key shortage drug reserve enterprises fill in the "Statistical Form for the Quantity of Shortage Drug Inventory" through the "National Pharmaceutical Reserve Management Information System".
.
.
For this notice, the industry believes that it fully reflects the state's problem of ensuring supply and stable prices for solving shortage drugs.
It is sparing no effort to further strengthen the supply and monitoring of key drugs by continuously improving the multi-departmental drug information collaborative monitoring mechanism and improving the supply level of drugs in multiple dimensions
.

In fact, at this stage, the monitoring system must be used to solve the problem of the shortage of medicines
.

In the long run, only by forming a more complete and complete supply guarantee system for the shortage of medicines, can patients' "medical" reliance no longer be "in shortage"
.

In recent years, relevant departments in China have actually attached great importance to the problem of drug shortages, and in order to solve the problem of drug shortages, their supervision has been continuously tightened
.
For example, in April 2020, the National Health Commission and 11 member units issued the "Notice on Printing and Distributing the Measures for the Administration of the National Drug Shortage List (Trial)", which clearly stated that the state will strengthen the list of drugs in shortage and the key monitoring list of clinically necessary drugs that are prone to shortage.
Monitoring and early warning of abnormal drug prices, strengthening the normalization of price supervision, increasing the enforcement of illegal acts such as monopoly of raw materials, and properly handling the problem of excessive drug price rises
.

In November 2021, the State Food and Drug Administration developed and constructed the information collection module for the production supply and discontinuation report of shortage drugs in the drug information collection platform
.

In January 2022, the "14th Five-Year" Pharmaceutical Industry Development Plan jointly issued by the Ministry of Industry and Information Technology, the National Development and Reform Commission and other nine departments also proposed that it is necessary to enhance the supply guarantee capacity of drugs that are prone to shortage, and dynamically adjust the national list of drugs in shortage and the key points of clinically necessary drugs that are prone to shortage.
Monitoring list, strengthening the production and supply chain monitoring and early warning of drugs that are prone to shortage, and establishing a supply and demand docking platform for drugs that are prone to shortage
.

Industry analysts believe that with the continuation of the national medical reform and the gradual advancement and implementation of various policies to solve the problem of drug shortages, the problem of drug shortages in China is expected to be gradually solved
.

In fact, with the implementation of a series of favorable policies in recent years, the problem of drug shortages has been continuously improved
.

As early as November 27, 2018 at the press conference of the National Health and Health Commission, the relevant person in charge stated that the Health and Health Commission has established a sound drug shortage monitoring context and hierarchical response system, and identified more than 500 shortage drug monitoring sentinels.
A list of 139 clinically in short supply drugs has been sorted out, and most of them have resumed production and supply
.

Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.